| Property | Value |
|---|---|
| Gene Symbol | DCTN6 |
| Full Name | Dynactin Subunit 6 |
| Chromosomal Location | 8p23.1 |
| NCBI Gene ID | 10671 |
| Ensembl ID | ENSG00000125850 |
| Encoded Protein | DCTN6 Protein |
| Core Complex | Dynactin |
DCTN6 encodes the p27/p25-family dynactin shoulder component often referred to as dynactin subunit 6. It is part of the dynactin complex that works with cytoplasmic dynein to move cargoes toward microtubule minus ends.[1][2] In neurons, dynein-dynactin transport is central for long-distance retrograde trafficking from synapses and distal axons to the soma, where cargoes are sorted for signaling, recycling, or degradation.[3][4]
Direct human disease causality for DCTN6 itself remains limited compared with stronger genetic data for DCTN1, DYNC1H1, and adaptor machinery. However, pathway-level evidence strongly supports that reduced dynein-dynactin efficiency can converge on phenotypes relevant to Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis (ALS) through impaired proteostasis, axonal trafficking failure, and stress signaling.[3:1][5]
Dynactin is a multisubunit assembly with an Arp1 filament backbone and a shoulder/sidearm region that coordinates dynein engagement and cargo coupling.[1:1][2:1] DCTN6 is positioned in the shoulder-associated module with other small subunits and contributes to complex stability and interaction geometry rather than acting as a catalytic enzyme. Inference from structural and biochemical dynactin studies suggests that perturbation of shoulder integrity can reduce productive dynein activation events.[1:2][2:2]
Dynein processivity and force output are enhanced when dynein engages dynactin plus activating adaptors (for example BICD-family adaptors).[2:3][6] Although most mechanistic experiments are not DCTN6-specific, they indicate that intact dynactin composition is necessary for:
These transport axes intersect directly with neurodegeneration-relevant mechanisms such as Autophagy-Lysosomal Dysfunction, Mitochondrial Dysfunction, and Protein Aggregation.[4:1][5:1][7]
Bulk transcriptomic datasets report broad DCTN6 expression with notable representation in neuronal tissue, consistent with the high transport burden of polarized neurons. Protein-level assignment places DCTN6 in cytoplasmic/cytoskeletal compartments as part of dynactin assemblies.[8][9] In practical terms, disease relevance is expected to be context-dependent: neurons with long axons and high vesicle turnover are the most sensitive to even modest transport defects.
This evidence hierarchy is important when interpreting therapeutic hypotheses that target transport complexes broadly.
Because DCTN6 sits inside a non-redundant trafficking machine, direct inhibition is unlikely to be therapeutic. Current translational logic instead focuses on restoring network function across transport-proteostasis pathways:
Future studies that combine cell-type-specific perturbation of DCTN6 with live-cargo imaging and human variant annotation will be needed to define whether DCTN6 can become a precision target rather than a pathway marker.[6:1][7:2]
Urnavicius L, et al. Cryo-EM shows how dynactin recruits two dyneins for faster movement. Nature. 2018. ↩︎ ↩︎ ↩︎
Schlager MA, et al. In vitro reconstitution of a highly processive recombinant human dynein complex. EMBO J. 2014. ↩︎ ↩︎ ↩︎ ↩︎
Moughamian AJ, Holzbaur ELF. Dynactin is required for transport initiation from the distal axon. Neuron. 2014. ↩︎ ↩︎ ↩︎
Millecamps S, Julien JP. Axonal transport deficits and neurodegenerative diseases. Nat Rev Neurosci. 2013. ↩︎ ↩︎ ↩︎ ↩︎
De Vos KJ, Grierson AJ, Ackerley S, Miller CCJ. Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci. 2008. ↩︎ ↩︎ ↩︎ ↩︎
Reck-Peterson SL, Redwine WB, Vale RD, Carter AP. The cytoplasmic dynein transport machinery and its many cargoes. Nat Rev Mol Cell Biol. 2018. ↩︎ ↩︎
Farfel-Becker T, et al. Neuronal Soma-Lysosomal Degradation Pathway and Implications in Neurodegeneration. Neuron. 2019. ↩︎ ↩︎ ↩︎
Uhlen M, et al. A pathology atlas of the human cancer transcriptome. Science. 2017. ↩︎
UniProt Consortium. DCTN6 entry (O43879). UniProt. ↩︎